ASSESSING AND EMPOWERING COUNSELLING A PATIENT WITH SEVERE DENGUE FEVER ASSOCIATED WITH THROMBOCYTOPENIA
Dengue is one of the common mosquito-borne arbovirus infections, especially in India. Dengue virus is a single strand RNA virus, which composed of four serotypes and these serotypes, belongs to the flavivirus genus. Dengue viruses are normally transmitted through the bites of aedes mosquito species. Dengue is the most frequent cause of fever which is caused with thrombocytopenia. Dengue is probably a fatal ailment that is widely spread through the tropical and subtropical regions of the world affecting urban and semi-urban areas. It also becomes a dominant health concern globally in recent decades. The most serious complications of this infection are dengue haemorrhagic fever and dengue shock syndrome. 18 y old male patient was admitted to the general ward in thiruvallur government hospital with chief complaints of fever, vomiting and dehydration, cough with expectorant for a period of 3 d. The patient was diagnosed with dengue fever followed by thrombocytopenia and advised for proper rehydration therapy. The patient was initiated with prophylactic therapy and Oral Rehydration Solution. He was also treated by focusing points based on patient counselling to recover the current condition. The patient was counseled accordingly as regular sit-ups, with points focusing on disease condition and therapy prescribed. The current case was aimed to target on the counselling points for dengue, which made a better improvement in the patient with severe dengue fever with thrombocytopenia and this could be a measure as community awareness outlook to spread alertness which can avoid the outbreak of Dengue.Â
2. Medagoda K, Gunathilaka SB, De Silva HJ. A case of self-limiting coombsâ€™ negative hemolytic anemia following dengue shock syndrome. Ceylon Med 2003;48:147â€“8.
3. Verma R, Jatav VK, Sharma S. Identification of inhibitors of dengue virus (DENV1, DENV2 AND DENV3) NS2B/NS3 serine protease: a molicular docking and simulation approach. Asian J Pharm Clin Res 2015;8:287-92.
4. Whitehorn J, Farrar J. Dengue. Br Med Bul 1995;95:161â€“73.
5. Khan DM, Kuppusamy K, Sumathi S, Mrinalini VR. Evaluation of thrombocytopenia in dengue infection along with seasonal variation in rural melmaruvathur. J Clin Diagn Res 2014; 8:39â€“42.
6. Garg S, Arora R, Kakkar N. Fever and petechiae in a middle aged male. Labmedicine 2007;38:23-5.
7. Tayade MR, Shinkar DM, Patil PB, Saudagar RB. Emerging therapy for dengue. Int J Curr Pharm Res 2018;10:1-4.
8. Kulkarn D, Sharma B. Dengue fever-induced cold-agglutinin syndrome. Ther Adv Infect Dis 2014;2:97â€“9.
9. Dutta D, Kuila P, Chatterjee D, Das S. Co-infection of brucella and dengue virus. Asian J Pharm Clin Res 2017;10:299-301.
10. Aroor AR, Saya RP, Sharma A, Venkatesh A, Alva R. Clinical manifestations and predictors of thrombocytopenia in hospitalized adults with dengue fever. N Am J Med Sci 2015;7:547â€“52.
11. Radakovic S, Graninger W, MÃ¼ller C, HÃ¶nigsmann H, Tanew A. Dengue hemorrhagic fever in a British travel guide. J Am Acad Dermatol 2002;46:430â€“3.
12. Liao B, Tang Y. Serum levels of soluble vascular cell adhesion molecules may correlate with the severity of dengue virus infection in adults. Emer Microbes Infect 2015;4:e24.
13. Gupta MK, Shrivastava AK, Chauhan APS, Gaur DS, Mishra KK, Sharma S. Comparative study of the shiva guggulu and simhanada guggulu in the management of amavata (rheumatoid arthritis). Int J Appl Pharm 2016;8:5-12.
14. Farista R, Muragundi PM. Practical possibilities to empower patients in the management of inflammatory bowel disease. J Crit Rev 2016;3:1-5.
15. Harikesh Maurya H, Tirath Kumar T. A review on comprehensive overview in the management of nephrotic disorders. J Crit Rev 2016;3:34-43.